Mature MSLN is actively secreted in fluids (ascites and blood) of tumor-bearing patients, as the result of aberrant splicing or juxtamembrane cleavage (soluble mesothelin related protein, SMRP) [30]. The gene discussed is MSLN; the disease is neoplasm.